Roche to buy U.S. biotech firm InterMune for $8.3 billion
Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for USD8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.
Aug 24, 2014, 23:54 PM IST